You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Aerosolized platinum nanoparticle chemotherapy for lung cancer

    SBC: HYLAPHARM LLC            Topic: 102

    Significance Lung cancer is the leading cause of cancer deaths with over new diagnoses annually Survival rate of lung cancer patients is correlated with the extent of lymph node metastasis Standard care includes chemotherapy radiation and or surgery Cisplatin is a first line chemotherapy for lung cancer but systemic intravenous IV delivery is confounded by various toxicities rena ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  2. Polo box PLK Inhibitors Target Tumors Resistant to ATP Competitive Compounds

    SBC: PPI PHARMACEUTICALS, LLC            Topic: NCI

    Polo like kinase PLK is a central player in regulating entry into and progression through mitosis Many studies have validated PLK as an anti tumor drug target and its inhibition is potently anti proliferative to cancer cells However recent data suggests that there are two major disadvantages of the conventional approach to blocking the kinase activity of PLK First both general kinome ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  3. A Novel Scaffold to Promote Skin Regeneration

    SBC: FirstString Research, Inc            Topic: NIAMS

    PROJECT SUMMARY Dermal scarring affects more than million people worldwide annually over million people are injured in motor vehicle accidents over million patients are severely burned and thousands of warriors are wounded in military blasts In severe burns more than of patients develop hypertrophic scar contraction which leads to hypertrophic scar contractures HSc HSc a ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  4. A Novel Millimeter wave mmw DNP EPR Front end Compatible with Versatile High field NMR Probes

    SBC: DOTY SCIENTIFIC, INC.            Topic: NIA

    A Novel Millimeter wave mmw DNP EPR Front end Compatible with Versatile High field NMR Probes Abstract There has been explosive growth in interest in Dynamic Nuclear Polarization DNP with Magic Angle Spinning MAS over the past five years because it has demonstrated S N gains exceeding two orders of magnitude at K compared to conventional MAS NMR and non spinning NMR of biological macro ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  5. Ice Free Vitrification and nanowarming of large cartilage samples for transplantation

    SBC: TISSUE TESTING TECHNOLOGIES LLC            Topic: NIAMS

    Resurfacing of articular cartilage with cold stored osteochondral allografts is employed clinically for repair of trauma and osteoarthritis induced articular cartilage surface damage Chondrocyte viability of transplanted articular cartilage is accepted as one of the determinants of outcome following osteochondral allograft transplantation We have previously developed an ice free vitrification me ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  6. Precision Microspheres for Transtympanic Delivery of Ganciclovir for CMV Infection

    SBC: ORBIS BIOSCIENCES, INC.            Topic: Y

    PROJECT SUMMARY Current approaches to treat sensorineural hearing loss SNHL in newborns suffering from congenital cytomegalovirus CMV infection rely on off label systemic antiviral therapy requiring high dose long duration treatment with demonstrated hematologic toxicity carcinogenicity and teratogenicity Furthermore it is unknown whether systemic delivery of antivirals maintain inner e ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  7. SBIR Phase I Protein A membrane columns for rapid protein purification

    SBC: Purilogics, LLC            Topic: 400

    Project Summary This SBIR Phase I project is significant because it addresses a critical need for products that increase research productivity during drug discovery and development Improving research productivity plays a key role in translating biologics from research labs to approved medications efficiently and economically Product purification often limits the productivity and time delays in ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  8. Evaluation of a Connexin based Peptide for the Treatment of Age Related Macular Degeneration

    SBC: FirstString Research, Inc            Topic: N

    PROJECT SUMMARY ABSTRACT FirstString Research has identified a novel peptide that shows therapeutic potential in the treatment of age related macular degeneration AMD This Phase I SBIR will assess both the feasibility and mechanism of action involved in the topical delivery of a synthetic connexin based peptide aCT for the treatment of AMD AMD is a retinal disease in patients who progress ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  9. Low cost portable system for the rapid detection and drug resistance profiling of Tuberculosis in low resource environments

    SBC: Impedx Diagnostics Inc.            Topic: NICHD

    Tuberculosis TB is one of the major public health challenges in the world today with an estimated million deaths in More alarmingly the incidence of multi drug resistant MDR TB is rapidly increasing especially in low resource environments The goal of this project is to develop an inexpensive portable system and method using which it will be possible to both detect the presence of ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  10. AN ORGANOID AVATAR BIOBANK FOR CANCER DISPARITIES

    SBC: Delphi Genomics, LLC            Topic: NCI

    This project seeks to establish a colorectal cancer organoid avatar bio bank from an ethnically and genetically diverse patient population that is approximately African American We will make use of discarded de identified surgical specimens to establish dimensional cultures of tumor and matched normal colon stem cells organoids Organoid avatars will be characterized by WNT EGF and ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government